Litcius/Paper detail

Piezo1 activation attenuates thrombin-induced blebbing in breast cancer cells

P.W. O’Callaghan, Adam Engberg, Olle Eriksson, Nikos Fatsis-Kavalopoulos, Christina Stelzl, Gonzalo Sánchez, Olof Idevall‐Hagren, Johan Kreuger

2022Journal of Cell Science23 citationsDOIOpen Access PDF

Abstract

Cancer cells exploit a variety of migration modes to leave primary tumors and establish metastases, including amoeboid cell migration, which is typically reliant on bleb formation. Here we demonstrate that thrombin induces dynamic blebbing in the MDA-MB-231 breast cancer cell line and confirm that protease-activated receptor 1 (PAR1) activation is sufficient to induce this effect. Cell confinement has been implicated as a driving force in bleb-based migration. Unexpectedly, we found that gentle contact compression, exerted using a custom built 'cell press' to mechanically stimulate cells, reduced thrombin-induced blebbing. Thrombin-induced blebbing was similarly attenuated using the small molecule Yoda1, an agonist of the mechanosensitive Ca2+ channel Piezo1, and this attenuation was impaired in Piezo1-depleted cells. Additionally, Piezo1 activation suppressed thrombin-induced phosphorylation of ezrin, radixin and moesin (ERM) proteins, which are implicated in the blebbing process. Our results provide mechanistic insights into Piezo1 activation as a suppressor of dynamic blebbing, specifically that which is induced by thrombin.

Topics & Concepts

PIEZO1ThrombinEzrinMoesinBiologyCell biologyBleb (medicine)RadixinCancer researchThrombomodulinCellMechanosensitive channelsReceptorImmunologyCytoskeletonBiochemistryNeuroscienceIon channelPlateletTrabeculectomyGlaucomaErythrocyte Function and PathophysiologyBlood properties and coagulationCellular Mechanics and Interactions
Piezo1 activation attenuates thrombin-induced blebbing in breast cancer cells | Litcius